May 02, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: This week in Drug Discovery (19 – 23 January) 
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Drug development > This week in Drug Discovery (19 – 23 January) 
Drug development

This week in Drug Discovery (19 – 23 January) 

By Newsroom
Last updated: January 25, 2026
1 Min Read
Share


News round-up for 19 – 23 January by Bruno Quinney, Content Team at DDW. 

This week in DDW, innovative therapies have shown encouraging results in tackling melanoma and concussion. Elsewhere, a UK-Canadian partnership looks to advance vaccine technology. 

The top stories: 

 

Combination therapy could slash melanoma mortality risk 

An investigational mRNA-based individualised neoantigen therapy (INT) reduced the risk of high-risk melanoma recurrence or death by 49% when combined…



Source link

TAGGED:CanadaCell and gene therapyClinical trialConcussionELRIGEuropean Medicines AgencyMelanomaMerckModernaOxeia BiopharmaceuticalsregulatoryUKVaccines
Share This Article
Facebook Email Copy Link Print

HOT NEWS

Ontario passes first wave of streamlining for the Clean Water Act

Environmental Science
November 23, 2025

Beyond Launch: 5 Ways Therapy Success Is Being Redefined

Download this White Paper to Learn More As the pharmaceutical landscape grows more competitive, launching…

May 2, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

This week in drug discovery (23-27 June) 

News round-up for 23-27 June by DDW Senior Digital Content Editor Diana Spencer.As we announce the DDW ‘Creating cures’ programme…

Drug development
June 27, 2025

‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented

Joshua Berus, PhD Maximilian Vargas, PhD Editor’s Note: Jiwon Oh provided research support for this article. She is a Certara…

Drug development
May 30, 2025

S&P report highlights Big Pharma’s concentration risk amid JPM deal flurry

Merck is an A+ credit, a global oncology powerhouse, and still, about half its 2024 pharma revenue came from a…

Drug development
January 11, 2026

Korean team reveals all-in-one cancer nanomedicine in pre-clinical studies

Researchers at the Korea Research Institute of Standards and Science (KRISS) have created a new nanomaterial that can simultaneously detect…

Drug development
July 4, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Beyond Launch: 5 Ways Therapy Success Is Being Redefined
May 2, 2026
Radiopharmaceuticals: Moving Beyond Innovation to Real-World…
May 2, 2026
Navigating Global Regulations for Radiopharmaceutical…
May 2, 2026
Radiopharmaceuticals Commercialization: What Determines…
May 1, 2026

Life Science Magazines

Beyond Launch: 5 Ways Therapy Success Is Being Redefined
May 2, 2026
Radiopharmaceuticals: Moving Beyond Innovation to Real-World…
May 2, 2026
Navigating Global Regulations for Radiopharmaceutical…
May 2, 2026
Radiopharmaceuticals Commercialization: What Determines…
May 1, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?